journal article·2026-07-04Open access

Amniotic Membrane-Derived Factors in Immunomodulation and Regenerative Medicine: Current Evidence and Emerging Perspectives in Biomaterials and 3D Bioprinting

Hristina Obradović, Ivana Gazikalović, Ivana Okić Đorđević, Sanja Momčilović, Dragana Aleksandrović, Nikola Jeftić, Aleksandra Jauković

Abstract

Human placenta-derived amniotic membrane (hAM) and its derivatives have attracted growing interest as bioactive materials for tissue engineering, regenerative medicine, and biomaterial design. This review summarizes the anatomical and cellular characteristics of hAM and examines the interplay between its regenerative and immunomodulatory properties. Key hAM-derived biomolecules are discussed, with an emphasis on their roles in immune regulation, angiogenesis, extracellular matrix remodeling, and tissue repair across diverse regenerative contexts. Current applications of hAM-based materials in tissue engineering and regenerative biomaterials are reviewed, including emerging studies involving soft tissue applications. In addition, recent efforts to integrate hAM derivatives into 3D bioprinting approaches are examined, including their use as bioink components or biofunctional additives to hydrogel-based systems. Although studies involving hAM-based bioprinted constructs remain limited, the available findings suggest promising regenerative, proangiogenic, and bioactive effects. Challenges related to material processing, printability, standardization, and reproducibility are also discussed. Overall, this review highlights the biomaterial potential of hAM derivatives and their emerging relevance to biofabrication strategies aimed at developing biologically instructive constructs for regenerative medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Corneal Surgery and Treatments · 3D Printing in Biomedical Research · Tissue Engineering and Regenerative Medicine

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Group for Hematology and Stem Cells, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia

Innovation Center of the Faculty of Technology and Metallurgy, University of Belgrade, 11000 Belgrade, Serbia

Group for Neuroendocrinology, Institute for Medical Research, National Institute of Republic of Serbia, University of Belgrade, 11000 Belgrade, Serbia

Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia

Funding

Science Fund of Republic of Serbia · Ministry of Education, Science and Technological Development of Republic of Serbia

References (100+)

Show source-provided references
1. Magatti, M., Masserdotti, A., Bonassi Signoroni, P., Vertua, E., Stefani, F.R., Silini, A.R., and Parolini, O. (2020). B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells. Front. Immunol., 11.10.3389/fimmu.2020.01156 ↗
2. Ramuta, T.Ž., Tratnjek, L., Janev, A., Seme, K., Starčič Erjavec, M., and Kreft, M.E. (2021). The Antibacterial Activity of Human Amniotic Membrane against Multidrug-Resistant Bacteria Associated with Urinary Tract Infections: New Insights from Normal and Cancerous Urothelial Models. Biomedicines, 9.10.3390/biomedicines9020218 ↗
3. Mao, Y., Jacob, V., Singal, A., Lei, S., Park, M.S., Lima, M.R.N., Li, C., Dhall, S., Sathyamoorthy, M., and Kohn, J. (2021). Exosomes Secreted from Amniotic Membrane Contribute to Its Anti-Fibrotic Activity. Int. J. Mol. Sci., 22.10.3390/ijms22042055 ↗
4. Janev, A., Ramuta, T.Ž., Tratnjek, L., Sardoč, Ž., Obradović, H., Mojsilović, S., Taskovska, M., Smrkolj, T., and Kreft, M.E. (2021). Detrimental Effect of Various Preparations of the Human Amniotic Membrane Homogenate on the 2D and 3D Bladder Cancer In Vitro Models. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.690358 ↗
5. Di Stefano, A.B., Urrata, V., Schilders, K., Franza, M., Di Leo, S., Moschella, F., Cordova, A., and Toia, F. (2025). Three-Dimensional Bioprinting Techniques in Skin Regeneration: Current Insights and Future Perspectives. Life, 15.10.3390/life15050787 ↗
6. Concurrently Bioprinted Scaffolds with Autologous Bone and Allogeneic BMSCs Promote Bone Regeneration through Native BMSC Recruitment10.1631/bdm.2400011 ↗
7. Wang, J., Deng, G., Wang, S., Li, S., Song, P., Lin, K., Xu, X., and He, Z. (2024). Enhancing Regenerative Medicine: The Crucial Role of Stem Cell Therapy. Front. Neurosci., 18.10.3389/fnins.2024.1269577 ↗
8. Immune Response: The Achilles’ Heel of the Stem Cell-Based Regenerative Therapies10.37349/ei.2023.00100 ↗
9. Harnessing the Innate and Adaptive Immune System for Tissue Repair and Regeneration: Considering More than Macrophages10.1016/j.actbio.2021.02.023 ↗
10. Promoting Tissue Regeneration by Modulating the Immune System10.1016/j.actbio.2017.01.056 ↗
11. Contribution of Platelets, the Coagulation and Fibrinolytic Systems to Cutaneous Wound Healing10.1016/j.thromres.2019.05.001 ↗
12. Mechanisms of Organ Injury and Repair by Macrophages10.1146/annurev-physiol-022516-034356 ↗
13. Lung-Resident Tissue Macrophages Generate Foxp3+ Regulatory T Cells and Promote Airway Tolerance10.1084/jem.20121849 ↗
14. Clinical Application of Mesenchymal Stem Cell in Regenerative Medicine: A Narrative Review10.1186/s13287-022-03054-0 ↗
15. Suppression of Neutrophil-Mediated Tissue Damage—A Novel Skill of Mesenchymal Stem Cells10.1002/stem.2417 ↗
16. Advances in Mesenchymal Stem Cell Therapy for Immune and Inflammatory Diseases: Use of Cell-Free Products and Human Pluripotent Stem Cell-Derived Mesenchymal Stem Cells10.1002/sctm.21-0021 ↗
17. Huang, Y., Wu, Q., and Tam, P.K.H. (2022). Immunomodulatory Mechanisms of Mesenchymal Stem Cells and Their Potential Clinical Applications. Int. J. Mol. Sci., 23.10.3390/ijms231710023 ↗
18. Proteomic Analysis of the Secretome of Human Bone Marrow-Derived Mesenchymal Stem Cells Primed by pro-Inflammatory Cytokines10.1016/j.jprot.2017.07.012 ↗
19. Exosomes Derived from M0, M1 and M2 Macrophages Exert Distinct Influences on the Proliferation and Differentiation of Mesenchymal Stem Cells10.7717/peerj.8970 ↗
20. Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis10.1016/j.stem.2012.03.007 ↗
21. Mesenchymal Stem Cell Effects on T-Cell Effector Pathways10.1186/scrt75 ↗
22. Effects of Mesenchymal Stromal Cells on Regulatory T Cells: Current Understanding and Clinical Relevance10.1002/stem.3151 ↗
23. Human Mesenchymal Stem Cells Modulate B-Cell Functions10.1182/blood-2005-07-2657 ↗
24. Interactions Between Human Mesenchymal Stem Cells and Natural Killer Cells10.1634/stemcells.2004-0359 ↗
25. Immunomodulatory Effects of Mesenchymal Stem Cells on Leukocytes with Emphasis on Neutrophils10.1016/j.imbio.2018.08.002 ↗
26. Mesenchymal Stem Cells Reciprocally Regulate the M1/M2 Balance in Mouse Bone Marrow-Derived Macrophages10.1038/emm.2013.135 ↗
27. Modulation of the Activity of Stem and Progenitor Cells by Immune Cells10.1093/stcltm/szab022 ↗
28. Immunosuppressive Properties of Mesenchymal Stromal Cells Derived from Amnion, Placenta, W Harton’s Jelly and Umbilical Cord10.1111/imj.12044 ↗
29. Mesenchymal Stem Cells from Human Amniotic Membrane and Umbilical Cord Can Diminish Immunological Response in an in Vitro Allograft Model10.1159/000449199 ↗
30. Integrating 3D Bioprinting and Organoids to Better Recapitulate the Complexity of Cellular Microenvironments for Tissue Engineering10.1002/adhm.202403762 ↗
31. Advanced Immunomodulatory Biomaterials for Therapeutic Applications10.1002/adhm.202304496 ↗
32. The Placenta: A Multifaceted, Transient Organ10.1098/rstb.2014.0066 ↗
33. Creasy, R.K., and Resnik, R. (2009). Creasy and Resnik’s Maternal-Fetal Medicine: Principles and Practice: Expert Consult Online + Print, Elsevier, Saunders. [6th ed.].
34. Benirschke, K., Kaufmann, P., and Baergen, R.N. (2006). Pathology of the Human Placenta, Springer Science + Business Media, Inc.. [5th ed.].
35. Mamede, A., and Botelho, M.F. (2015). Amniotic Membrane: Origin, Characterization and Medical Applications, Springer.10.1007/978-94-017-9975-1 ↗
36. Parolini, O., Solomon, A., Evangelista, M., and Soncini, M. (2010). Human Term Placenta as a Therapeutic Agent: From the First Clinical Applications to Future Perspectives. Human Placenta: Structure and Development, Circulation and Functions, Nova Biomedical Books.
37. Scale-Up of Human Amniotic Epithelial Cells Through Regulation of Epithelial-Mesenchymal Plasticity Under Defined Conditions10.1002/advs.202408581 ↗
38. Biological Characterization of Human Amniotic Epithelial Cells in a Serum-Free System and Their Safety Evaluation10.1038/aps.2018.22 ↗
39. Comparison of the Proliferation, Migration and Angiogenic Properties of Human Amniotic Epithelial and Mesenchymal Stem Cells and Their Effects on Endothelial Cells10.3892/ijmm.2017.2897 ↗
40. Properties of the Amniotic Membrane for Potential Use in Tissue Engineering10.22203/eCM.v015a07 ↗
41. Stem Cell Characteristics of Amniotic Epithelial Cells10.1634/stemcells.2004-0357 ↗
42. Concise Review: Isolation and Characterization of Cells from Human Term Placenta: Outcome of the First International Workshop on Placenta Derived Stem Cells10.1634/stemcells.2007-0594 ↗
43. García-Castro, I.L., García-López, G., Ávila-González, D., Flores-Herrera, H., Molina-Hernández, A., Portillo, W., Ramón-Gallegos, E., and Díaz, N.F. (2015). Markers of Pluripotency in Human Amniotic Epithelial Cells and Their Differentiation to Progenitor of Cortical Neurons. PLoS ONE, 10.10.1371/journal.pone.0146082 ↗
44. Induced in Vitro Differentiation of Pancreatic-like Cells from Human Amnion-Derived Fibroblast-like Cells10.1111/j.1749-0774.2009.00069.x ↗
45. Xenografted Human Amniotic Membrane-Derived Mesenchymal Stem Cells Are Immunologically Tolerated and Transdifferentiated into Cardiomyocytes10.1161/CIRCRESAHA.109.205260 ↗
46. Mapping of the Human Amniotic Membrane: In Situ Detection of Microvesicles Secreted by Amniotic Epithelial Cells10.1177/09636897231166209 ↗
47. Fathi, I., and Miki, T. (2022). Human Amniotic Epithelial Cells Secretome: Components, Bioactivity, and Challenges. Front. Med., 8.10.3389/fmed.2021.763141 ↗
48. Epidermal Growth Factor Variations in Amniotic Membrane Used for Ex Vivo Tissue Constructs10.1089/ten.tea.2008.0432 ↗
49. Cytokine Dosage in Fresh and Preserved Human Amniotic Membrane10.1097/ICO.0000000000000673 ↗
50. How Preparation and Preservation Procedures Affect the Properties of Amniotic Membrane? How Safe Are the Procedures?10.1016/j.burns.2019.07.005 ↗
51. The Effect of Storage Time of Fresh Human Amniotic Membrane on the Levels of Growth Factors Epidermal Growth Factor, Transforming Growth Factor Beta, and Basic Fibroblast Growth Factor in Freeze-Dried Human Amniotic Membrane after Gamma Ray Irradiation10.4103/bhsj.bhsj_37_24 ↗
52. An Epidermal Stem Cells Niche Microenvironment Created by Engineered Human Amniotic Membrane10.1016/j.biomaterials.2011.06.076 ↗
53. Mapping of Proteomic Profile and Effect of the Spongy Layer in the Human Amniotic Membrane10.1007/s10561-020-09821-8 ↗
54. Growth Factor and Interleukin Concentrations in Amniotic Membrane-Conditioned Medium10.3109/02713683.2016.1164189 ↗
55. The Influence of Amniotic Membrane Extracts on Cell Growth Depends on the Part of Membrane and Childbirth Mode Selected: A Proof-of-Concept Study10.12968/jowc.2017.26.8.498 ↗
56. Amniotic Membrane-Derived Stem Cells: Immunomodulatory Properties and Potential Clinical Application
57. Yang, P., and Zhang, J. (2023). Indoleamine 2,3-Dioxygenase (IDO) Activity: A Perspective Biomarker for Laboratory Determination in Tumor Immunotherapy. Biomedicines, 11.10.3390/biomedicines11071988 ↗
58. Prostaglandin E2 and T Cells: Friends or Foes?10.1038/icb.2011.75 ↗
59. Decellularized Amnion Membrane Triggers Macrophage Polarization for Desired Host Immune Response10.1002/adhm.202402139 ↗
60. Bulati, M., Miceli, V., Gallo, A., Amico, G., Carcione, C., Pampalone, M., and Conaldi, P.G. (2020). The Immunomodulatory Properties of the Human Amnion-Derived Mesenchymal Stromal/Stem Cells Are Induced by INF-γ Produced by Activated Lymphomonocytes and Are Mediated by Cell-To-Cell Contact and Soluble Factors. Front. Immunol., 11.10.3389/fimmu.2020.00054 ↗
61. Immunomodulatory Effects of Human Amniotic Membrane-Derived Mesenchymal Stem Cells10.4142/jvs.2012.13.1.23 ↗
62. The Immunosuppressive Capacity of Human Mesenchymal Stromal Cells Derived from Amnion and Bone Marrow
63. Amniotic MSC Affect CD8 Naive Polarization toward SLEC/MPEC Subsets by down-Modulating IL-12Rβ1 and IL-2Rα Signaling Pathways10.1016/j.isci.2023.108483 ↗
64. Immunosuppressive Potential of Human Amnion Epithelial Cells in the Treatment of Experimental Autoimmune Encephalomyelitis10.1186/s12974-015-0322-8 ↗
65. Morandi, F., Marimpietri, D., Görgens, A., Gallo, A., Srinivasan, R.C., El-Andaloussi, S., and Gramignoli, R. (2020). Human Amnion Epithelial Cells Impair T Cell Proliferation: The Role of HLA-G and HLA-E Molecules. Cells, 9.10.3390/cells9092123 ↗
66. Human Amniotic Membrane-Derived Mesenchymal and Epithelial Cells Exert Different Effects on Monocyte-Derived Dendritic Cell Differentiation and Function10.3727/096368914X684033 ↗
67. Human Amniotic Epithelial Stem Cell Is a Cell Therapy Candidate for Preventing Acute Graft-versus-Host Disease10.1038/s41401-024-01283-y ↗
68. CM from Intact hAM: An Easily Obtained Product with Relevant Implications for Translation in Regenerative Medicine10.1186/s13287-021-02607-z ↗
69. Comparative Study of the Production of Soluble Factors in Human Placenta-Derived Mesenchymal Stromal/Stem Cells Grown in Adherent Conditions or as Aggregates in a Catheter-like Device10.1016/j.bbrc.2019.11.069 ↗
70. Estúa-Acosta, G.A., Buentello-Volante, B., Magaña-Guerrero, F.S., Flores, J.E.-A., Vivanco-Rojas, O., Castro-Salas, I., Zarco-Ávila, K., García-Mejía, M.A., and Garfias, Y. (2022). Human Amniotic Membrane Mesenchymal Stem Cell-Synthesized PGE2 Exerts an Immunomodulatory Effect on Neutrophil Extracellular Trap in a PAD-4-Dependent Pathway through EP2 and EP4. Cells, 11.10.3390/cells11182831 ↗
71. Human Amnion Epithelial Cells and Secretome Drive the Generation of Tolerogenic Macrophages and Decidua-like NK Cells with Lower Proliferative Capability and Higher Effector Functions10.1016/j.jcyt.2025.03.066 ↗
72. Exosomes as Immunomodulators in Autoimmune Inflammation: Implications for Primary Sjögren’s Disease10.1007/s00011-025-02053-0 ↗
73. Amnion Epithelial Cell-Derived Exosomes Restrict Lung Injury and Enhance Endogenous Lung Repair10.1002/sctm.17-0185 ↗
74. Alhomrani, M., Correia, J., Zavou, M., Leaw, B., Kuk, N., Xu, R., Saad, M.I., Hodge, A., Greening, D.W., and Lim, R. (2017). The Human Amnion Epithelial Cell Secretome Decreases Hepatic Fibrosis in Mice with Chronic Liver Fibrosis. Front. Pharmacol., 8.10.3389/fphar.2017.00748 ↗
75. Human Amniotic Mesenchymal Stem Cells and Their Paracrine Factors Promote Wound Healing by Inhibiting Heat Stress-Induced Skin Cell Apoptosis and Enhancing Their Proliferation through Activating PI3K/AKT Signaling Pathway10.1186/s13287-019-1366-y ↗
76. LOXL2 from Human Amniotic Mesenchymal Stem Cells Accelerates Wound Epithelialization by Promoting Differentiation and Migration of Keratinocytes10.18632/aging.103384 ↗
77. Paracrine Effects of Human Amniotic Epithelial Cells Protect against Chemotherapy-Induced Ovarian Damage10.1186/s13287-017-0721-0 ↗
78. Impact of Human Amniotic Membrane Preparation on Release of Angiogenic Factors10.1002/term.207 ↗
79. Side Dependent Effects of the Human Amnion on Angiogenesis10.1016/j.placenta.2013.02.001 ↗
80. The Effects of Cryopreservation on Angiogenesis Modulation Activity of Human Amniotic Membrane10.1016/j.cryobiol.2015.09.008 ↗
81. Angiogenic Potential of Cryopreserved Amniotic Membrane Is Enhanced Through Retention of All Tissue Components in Their Native State10.1089/wound.2015.0638 ↗
82. In Vitro Anti-Angiogenic Effects of Cryo-Preserved Amniotic Membrane and the Role of TIMP2 and Thrombospondin10.1016/j.xjec.2017.09.001 ↗
83. Neovascularization in a Mouse Model via Stem Cells Derived from Human Fetal Amniotic Membranes10.1007/s00380-010-0064-6 ↗
84. Growth Factors and Their Receptors Derived from Human Amniotic Cells in Vitro10.5603/FHC.2014.0019 ↗
85. Transplanted Human Amniotic Epithelial Cells Secrete Paracrine Proangiogenic Cytokines in Rat Model of Myocardial Infarction10.3727/096368914X685609 ↗
86. Noh, C.H., Park, S., Seong, H.-R., Lee, A., Tsolmon, K.-E., Geum, D., Hong, S.-C., Kim, T.M., Choi, E.-K., and Kim, Y.-B. (2023). An Exosome-Rich Conditioned Medium from Human Amniotic Membrane Stem Cells Facilitates Wound Healing via Increased Reepithelization, Collagen Synthesis, and Angiogenesis. Cells, 12.10.20944/preprints202311.1137.v1 ↗
87. The Angiogenic Properties of Human Amniotic Membrane Stem Cells Are Enhanced in Gestational Diabetes and Associate with Fetal Adiposity10.1186/s13287-021-02678-y ↗
88. Human Amniotic Epithelial Cell-Derived Extracellular Vesicles Provide an Extracellular Matrix-Based Microenvironment for Corneal Injury Repair10.1177/20417314221122123 ↗
89. Exosomes Derived from Human Amniotic Epithelial Cells Accelerate Diabetic Wound Healing via PI3K-AKT-mTOR-Mediated Promotion in Angiogenesis and Fibroblast Function10.1093/burnst/tkaa020 ↗
90. Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Promotes Angiogenesis in hUVECs by Delivering Novel miRNA N-19410.1186/s10020-025-01192-8 ↗
91. Exosomes Derived from Human Amniotic Mesenchymal Stem Cells Facilitate Diabetic Wound Healing by Angiogenesis and Enrich Multiple lncRNAs10.1007/s13770-022-00513-w ↗
92. The Repairing of Full-Thickness Skin Deficiency and Its Biological Mechanism Using Decellularized Human Amniotic Membrane as the Wound Dressing10.1016/j.msec.2017.03.232 ↗
93. Human Acellular Amniotic Membrane Implantation for Lower Third Nasal Reconstruction: A Promising Therapy to Promote Wound Healing10.1186/s41038-018-0136-x ↗
94. Comparison of the Efficacy of Amniotic Membrane Versus Buccal Fat Pad in Treatment of Oral Submucous Fibrosis10.1007/s12663-022-01709-2 ↗
95. Amniotic Membrane In Palatal Epithelial-Connective Tissue Reconstruction
96. Efficient Wound Healing Using a Synthetic Nanofibrous Bilayer Skin Substitute in Murine Model10.1016/j.jss.2019.07.017 ↗
97. Engraftment of Bioengineered Three-Dimensional Scaffold from Human Amniotic Membrane-Derived Extracellular Matrix Accelerates Ischemic Diabetic Wound Healing10.1007/s00403-020-02137-3 ↗
98. Effect of Dermal Fibroblasts and Mesenchymal Stem Cells Seeded on an Amniotic Membrane Scaffold in Skin Regeneration: A Case Series10.1111/jocd.14043 ↗
99. Sabapathy, V., Sundaram, B., Vm, S., Mankuzhy, P., and Kumar, S. (2014). Human Wharton’s Jelly Mesenchymal Stem Cells Plasticity Augments Scar-Free Skin Wound Healing with Hair Growth. PLoS ONE, 9.10.1371/journal.pone.0093726 ↗
100. Bone Marrow Stem Cell and Decellularized Human Amniotic Membrane for the Treatment of Nonhealing Wound After Radiation Therapy10.6002/ect.MESOT2018.O29 ↗